aod9604 human clinical trials weight loss results efficacy AOD-9604: The Future of and Metabolism Enhancement AOD-9604: The Fat-Loss Peptide —
Description
Malavasi, F
Great Potential in the Treatment of Metabolic Diseases With the high prevalence of metabolic diseases worldwide, 5-amino-1-methylquinolinium has shown outstanding performance in animal models of obesity, glucose metabolism disorders, fatty liver disease and other conditions
It can also be used as an auxiliary treatment after bariatric surgery to improve postoperative skin laxity and fat residue
Favorable safety profile: The AOD9604 safety profile is one of its most important benefits for research
